A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.

Neurology and therapy（2023）

引用 0|浏览1

暂无评分

摘要

ClinicalTrials.gov identifier, NCT03887455.

查看译文

关键词

Alzheimer’s disease,Delay of onset,Disease-modifying therapy,Institutionalization,Lecanemab,Progression,Simulation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要